Faecal transplant makes the brains of old mice act young again

TL;DR

Researchers found that transplanting gut microbiomes from young mice into older mice enhances brain plasticity. This discovery points to the microbiome’s role in brain aging and development.

A study has shown that fecal microbiota transplants from young mice can restore neuroplasticity in aged mice, suggesting a new approach to addressing age-related decline in brain function. This finding highlights the potential of gut microbiome manipulation as a tool for brain health and recovery.

Researchers at the Sant’Anna School of Advanced Studies in Pisa conducted experiments on mice to explore whether altering the gut microbiome could influence brain plasticity, which declines with age. They administered broad-spectrum antibiotics to 21-day-old mice, which significantly changed their gut bacteria, including reductions in bacteria involved in producing neuroprotective short-chain fatty acids. When these mice underwent a visual plasticity test—sealing one eye—they showed diminished brain response compared to untreated mice, indicating reduced plasticity.

Further analysis revealed over 1,000 genes in the visual cortex were differentially expressed after antibiotic treatment, including genes related to nerve myelination and blood-brain barrier permeability. The most significant finding emerged when researchers transplanted fecal microbiota from young mice (around 30 days old) into 4-month-old adult mice. Only the mice receiving microbiota from young donors exhibited restored neuroplasticity, responding to the eye-shutting experiment with brain activity similar to that of younger mice.

While these results suggest a link between gut microbiome composition and brain plasticity, the researchers caution that direct application to humans remains uncertain. The study underscores the microbiome’s potential role in neural development and aging, but further research is needed to identify specific microbial strains or metabolites responsible for these effects.

Implications for Brain Aging and Recovery

If similar effects occur in humans, manipulating the gut microbiome could become a strategy to enhance learning, support recovery from neurological injuries, or combat age-related cognitive decline. Experts suggest that targeting microbial communities might offer new avenues for treating conditions like stroke, traumatic brain injury, or neurodegenerative diseases, where brain plasticity is crucial. However, translating these findings from mice to humans requires careful investigation to understand the complex interactions involved and to develop safe, effective interventions.

BioRx Sponix Pet Fecal Test Kit (50 Pack) - Professional Animal Stool Sample Collection Containers for Dogs & Cats - Leak-Proof Fecalyzer with Collection Spoons

BioRx Sponix Pet Fecal Test Kit (50 Pack) – Professional Animal Stool Sample Collection Containers for Dogs & Cats – Leak-Proof Fecalyzer with Collection Spoons

PROFESSIONAL GRADE: 50-pack of high-quality fecalyzers designed for veterinary clinics, animal shelters, and professional breeders.

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Microbiome and Brain Development: Prior Insights

The gut-brain axis has been a focus of research for years, with studies linking gut bacteria to mood, depression, and personality traits. Previous work indicated that early-life microbiome composition influences brain development, but this is the first study to demonstrate that altering microbiota in adulthood can restore plasticity. The use of antibiotics to modify gut bacteria and subsequent fecal transplants from young donors builds on existing knowledge that microbial communities impact immune function and neuroprotection. This research adds a new dimension by suggesting the microbiome’s active role in regulating critical periods of brain development and plasticity.

“This study suggests that microbial communities may help regulate critical periods of brain development by defining when developmental windows of heightened plasticity open and close.”

— an anonymous researcher

Bronson Brain + Mood Probiotic 50 Billion CFU Plus Prebiotic with L-Theanine, Bacopa and Rhodiola Non-GMO, 60 Vegetarian Capsules

Bronson Brain + Mood Probiotic 50 Billion CFU Plus Prebiotic with L-Theanine, Bacopa and Rhodiola Non-GMO, 60 Vegetarian Capsules

50 Billion CFU Freeze Dried Strains: Bronson Brain + Mood Probiotic 50 Billion CFU Plus Prebiotic provides 16…

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Unanswered Questions About Human Application

It remains unclear whether similar microbiome manipulations would produce comparable effects on brain plasticity in humans. The complexity of the human microbiome, differences in brain structure, and lifestyle factors make direct translation challenging. Additionally, the long-term effects of microbiota transplants and the specific microbial strains responsible for the observed benefits are still unknown. Researchers caution that more studies are needed to determine safety, efficacy, and mechanisms before considering clinical applications.

MARYRUTH'S Gut Flora Health+ Enzymes | Prebiotic & Probiotic Digestive Enzymes for Healthy Gut Biome & Digestive Support | Gastrointestinal Health | CLP Certified | 60 Capsules | 2 Month Supply

MARYRUTH'S Gut Flora Health+ Enzymes | Prebiotic & Probiotic Digestive Enzymes for Healthy Gut Biome & Digestive Support | Gastrointestinal Health | CLP Certified | 60 Capsules | 2 Month Supply

Gut Flora Health+ Enzymes: The gut’s microbiome plays a significant role in overall health! This robust prebiotic, probiotic…

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Next Steps for Research and Clinical Trials

Future research will focus on identifying specific microbial strains or metabolites responsible for enhancing neuroplasticity. Scientists aim to conduct studies in larger animals and, eventually, clinical trials in humans to assess safety and effectiveness. Researchers also plan to explore whether microbiome interventions could be used to treat neurological conditions, support recovery, or slow cognitive decline. Monitoring long-term outcomes and understanding potential risks will be critical before translating these findings into medical practice.

Researched Nutritionals BDNF Essentials - Clinically Researched Brain Supplement with Bacopa Monnieri & Lions Mane Mushroom - Supports Neuroplasticity, & Healthy Cortisol Levels, 120 Capsules

Researched Nutritionals BDNF Essentials – Clinically Researched Brain Supplement with Bacopa Monnieri & Lions Mane Mushroom – Supports Neuroplasticity, & Healthy Cortisol Levels, 120 Capsules

Promote Healthy Neurons & Cognition – BDNF Essentials is a clinically researched brain support formula that uses herbal…

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Key Questions

Could fecal transplants from young donors help treat age-related cognitive decline?

While the study shows promise in mice, it’s too early to say whether similar approaches would work in humans. More research is needed to identify the specific microbes involved and assess safety in humans.

Are antibiotics harmful to brain development?

Prolonged or high-dose antibiotic use during critical developmental periods may impact the microbiome and brain plasticity, but antibiotics are essential medicines. Use should be judicious, especially in early childhood, to minimize potential long-term effects.

What are the potential risks of manipulating the microbiome in adults?

Risks include unintended changes to gut bacteria, immune responses, or metabolic effects. Careful research is needed to develop targeted, safe interventions for humans.

How soon could microbiome-based therapies become available for neurological conditions?

It may take several years of research and clinical trials before such therapies are available, depending on the outcomes of ongoing studies and safety assessments.

Source: New Scientist


You May Also Like

Blue Origin’s New Glenn blows up during static fire test

Blue Origin’s New Glenn experienced a failure and exploded during a scheduled static fire test, raising questions about its development timeline and safety.

Jack Clark Says It Out Loud — Reading the Co-Founder’s 60%/2028 Estimate on Automated AI R&D

Anthropic’s co-founder Jack Clark publicly estimates over 60% probability that autonomous AI R&D occurs by 2028, signaling a major policy stance.

The Co-Founder’s Black Hole — A Structural Read on Jack Clark’s Automated AI R&D Essay

Jack Clark predicts over 60% chance of fully automated AI research by 2028, raising concerns about institutional capacity and future uncertainties.

Two Channels: How the Pentagon Just Split Frontier-AI Procurement in Half

The Pentagon announced a division of its AI procurement into two distinct channels, placing Anthropic in a strategic, non-redundant category, impacting future AI contracts.